---
nav_exclude: true
layout: default
title: "Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024"
source_url: "https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=744994"
source_layer: us_cdc_mmwr
category: surveillance_summary
date: 2024-03-07
confidence: 中
mmwr_volume: ""
mmwr_issue: ""
---

## 摘要

This report describes effectiveness of nirsevimab against respiratory syncytial virus-associated hospitalizations in infants. 

## 詳細內容

This report describes effectiveness of nirsevimab against respiratory syncytial virus-associated hospitalizations in infants. 

## 關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---
*萃取時間: 2026-02-05T15:10:06Z*
*資料來源: CDC MMWR*
